Sep 30, 2023 Posters & Publications
AUTHORS: Dia A. Smiley1, DO, Andrew J. Einstein1,2, MD, PhD, Denisse Santana Del Rosario1, MD, Nicholas Chan1, MD, Akiva Mintz2, MD, PhD, Kim Goldner2, CNMT,RT, Stephen T. Helmke1 RDCS, MPH, Margaret O. Cuomo1, NP, Ani Nalbandian1, MD, Sergio Teruya1, MD, Samantha...
Sep 30, 2023 Posters & Publications
AUTHORS: Dia Smiley, Andrew Einstein, Denisse Santana, Nicholas Chan, Akiva Mintz, Kimberly Goldner, Stephen Helmke, Margaret Cuomo, Ani Nalbandian, Sergio Teruya, Samantha Guadalupe, Jeffeny De Los Santos, Alfonsina Mirabel, Mary Paulino, Kimberly Collado, Carlos...
Dec 19, 2022 Press Releases
PDF Version SAN FRANCISCO – December 19, 2022 – Attralus, Inc., a clinical stage biopharmaceutical company developing transformative medicines to improve the lives of patients with systemic amyloidosis, announced today that the European Commission (EC) and European...
Sep 12, 2022 Press Releases
PDF Version AT-01 shows increased LV uptake and LV amyloid activity in all cardiac ATTR and AL subjects, but in none of the controls (100% accuracy) AT-01 demonstrates significantly higher left ventricular uptake in ATTR-CMP participants than florbetapir SAN...
Sep 8, 2022 Press Releases
PDF Version AT-01 is a first-in-class pan-amyloid imaging agent capable of detecting diverse types of systemic amyloidosis in multiple organs Sensitivity in those with previously diagnosed cardiac disease was 100% in ATTR and 93% in AL Organ-specific changes in...
